| 5 | | |
| 6 | | |
| 7 | | |
| 8 | | On 06 Jan 2026, at 14:27, ChimeraX <ChimeraX-bugs-admin@cgl.ucsf.edu> wrote: |
| 9 | | |
| 10 | | #19566: Mesh blocked by transparent surface |
| 11 | | --------------------------------+------------------------- |
| 12 | | Reporter: bec2@… | Owner: Tom Goddard |
| 13 | | Type: defect | Status: closed |
| 14 | | Priority: normal | Milestone: |
| 15 | | Component: Graphics | Version: |
| 16 | | Resolution: not a bug | Keywords: |
| 17 | | Blocked By: | Blocking: |
| 18 | | Notify when closed: | Platform: all |
| 19 | | Project: ChimeraX | |
| 20 | | --------------------------------+------------------------- |
| 21 | | Changes (by Tom Goddard): |
| 22 | | |
| 23 | | * resolution: => not a bug |
| 24 | | * status: assigned => closed |
| 25 | | |
| 26 | | Comment: |
| 27 | | |
| 28 | | If your mesh is opaque and your surface is transparent then the mesh is |
| 29 | | completely visible through the transparent surface. Your problem is the |
| 30 | | mesh is also transparent. The ChimeraX limitation is that with two |
| 31 | | transparent objects only the frontmost is visible. While this is a |
| 32 | | limitation it is also a useful feature. It gives a better appearance for |
| 33 | | transparent molecular surfaces of proteins with for example cavities |
| 34 | | because you only see the front-most surface instead of all the layers. |
| 35 | | The appearance with all the layers is complex and often less useful than |
| 36 | | the single-layer transparency. |
| 37 | | -- |
| 38 | | Ticket URL: <https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.rbvi.ucsf.edu%2Ftrac%2FChimeraX%2Fticket%2F19566%23comment%3A3&data=05%7C02%7Cbec2%40duke.edu%7Cae054e37b991468aee0108de4d59aca5%7Ccb72c54e4a314d9eb14a1ea36dfac94c%7C0%7C0%7C639033244728963814%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=7UVcifz%2F%2B2wh80Vj%2BsqITGjyUJpzMVWeLT2KYLC7sJg%3D&reserved=0> |
| 39 | | ChimeraX <https://nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.rbvi.ucsf.edu%2Fchimerax%2F&data=05%7C02%7Cbec2%40duke.edu%7Cae054e37b991468aee0108de4d59aca5%7Ccb72c54e4a314d9eb14a1ea36dfac94c%7C0%7C0%7C639033244728990128%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=U%2FG8jRBbcAK%2FNzD6p5RHpegg9GvbMRw46YAPEBeL%2FLQ%3D&reserved=0> |
| 40 | | ChimeraX Issue Tracker |
| 41 | | |
| 42 | | --- |
| 43 | | Brian E. Coggins, Ph.D. |
| 44 | | Assistant Research Professor of Biochemistry |
| 45 | | Duke University, Durham, NC |
| 46 | | |
| 47 | | |
| 48 | | |
| 49 | | }}} |